Researchers in Israel reported that a third dose of the Pfizer-BioNTech Covid vaccine can enhance protection in adults older than 60 for at least 12 days — a result that is unsurprising, experts said, and does not indicate long-term benefit. https://t.co/OKF8OSY1Cr

— The New York Times (@nytimes) September 15, 2021